Clinical Trial Update: Clinical Research Study With Clazosentan to Evaluate Its Effects on Preventing Complications Due to the Narrowing of the Blood Vessels (Vasospasm) in the Brain, Caused by Bleeding Onto the Surface of the Brain [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating clazosentan for preventing vasospasm-related complications after aneurysmal subarachnoid hemorrhage has completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysmal Subarachnoid Hemorrhage

Drugs mentioned

• Clazosentan (clazosentan)

Snippet

Sponsor: Idorsia Pharmaceuticals Ltd. | Conditions: Aneurysmal Subarachnoid Hemorrhage | Phase 3 | Status: COMPLETED | Results posted: 2024-01-10